Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,128 | -30,514 | -15,085 | -132,065 | -35,513 |
| Depreciation Amortization | 352 | 242 | 128 | 807 | 664 |
| Accounts receivable | 6,810 | 124 | 68 | -20 | 3,699 |
| Accounts payable and accrued liabilities | 4,484 | 4,107 | 1,664 | -4,188 | -1,216 |
| Other Working Capital | -564 | -1,176 | -1,935 | 10,922 | 11,916 |
| Other Operating Activity | 64 | 4,167 | 2,103 | 104,469 | 9,313 |
| Operating Cash Flow | $-33,982 | $-23,050 | $-13,057 | $-20,075 | $-11,137 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87 | -64 | -43 | -121 | -121 |
| Purchase Of Investment | -35,124 | -29,926 | -9,996 | -119,982 | -49,555 |
| Sale Of Investment | 74,040 | 54,989 | 29,991 | 86,144 | 68,630 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -35,810 | N/A |
| Other Investing Activity | -833 | -833 | -833 | -35,810 | 0 |
| Investing Cash Flow | $37,996 | $24,166 | $19,119 | $-69,769 | $18,954 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | N/A | 74,945 | 32 |
| Other Financing Activity | -3,328 | -284 | -275 | -409 | -76 |
| Financing Cash Flow | $-3,328 | $-284 | $-275 | $74,536 | $-44 |
| Beginning Cash Position | 24,570 | 24,570 | 24,570 | 39,878 | 39,878 |
| End Cash Position | 25,256 | 25,402 | 30,357 | 24,570 | 47,651 |
| Net Cash Flow | $686 | $832 | $5,787 | $-15,308 | $7,773 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,982 | -23,050 | -13,057 | -20,075 | -11,137 |
| Capital Expenditure | -87 | -64 | -43 | -121 | -121 |
| Free Cash Flow | -34,069 | -23,114 | -13,100 | -20,196 | -11,258 |